Sana Biotechnology: Funding, Investors & Team (Sep 2026)
Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases. The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.
Sana Biotechnology has raised $1.0B across 5 funding rounds on record, the most recent an undisclosed round of $69.0M announced in May 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Sana Biotechnology Company Profile and Key Stats
Latest funding round on record: May 2026.
Sana Biotechnology Funding Rounds
Sana Biotechnology raised $700M in an undisclosed round announced in Jun 2020.
3.7 years later, an undisclosed round of $165M was announced in Feb 2024.
1.5 years later, an undisclosed round of $86.3M was announced in Aug 2025.
8 months later, an undisclosed round of $25.0M was announced in Apr 2026.
1 month later, an undisclosed round of $69.0M was announced in May 2026.
Sana Biotechnology Founders and Leadership Team
Contact details for the Sana Biotechnology team: 2 of 4 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Sana Biotechnology Funding Compared to Other Biotechnology Startups
Sana Biotechnology's latest round of $69.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sana Biotechnology in Biotechnology and Seattle
Companies Similar to Sana Biotechnology
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Sana Biotechnology Funding FAQs
What does Sana Biotechnology do?
Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases. The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.
How much funding has Sana Biotechnology raised?
Sana Biotechnology has raised $1.0B across 5 rounds on record. The most recent is an undisclosed round of $69.0M announced in May 2026.
When did Sana Biotechnology last raise funding?
Sana Biotechnology's most recent funding round on record is an undisclosed round of $69.0M, announced in May 2026.
Who founded Sana Biotechnology?
FundedIQ lists Brian Piper (Founder), Nikolaus Froehner (Founder), Sonja Schrepfer (Founder) at Sana Biotechnology.
Who is the CEO of Sana Biotechnology?
Steve Harr is listed as CEO at Sana Biotechnology.
Where is Sana Biotechnology headquartered?
Sana Biotechnology is based in Seattle, Washington, United States.
How many employees does Sana Biotechnology have?
Sana Biotechnology is in the 251-500 employee band.
How does Sana Biotechnology's funding compare to other Biotechnology startups?
Sana Biotechnology's latest round of $69.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Sana Biotechnology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sana Biotechnology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.